Findings could aid treatment of resistant T-ALLOctober 18, 2016Leukemia, Myelodysplasia, TransplantationALL
Proteins may be therapeutic targets for AML subtypeOctober 17, 2016Leukemia, Myelodysplasia, TransplantationAML
CHMP recommends conditional approval of drug for CLLOctober 15, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Device could aid treatment decisions in ALL, other cancersOctober 13, 2016Leukemia, Myelodysplasia, Transplantation
Immunotherapy produces CRs in kids with rel/ref ALLOctober 7, 2016Leukemia, Myelodysplasia, TransplantationPediatricsALL
Drug granted conditional approval to treat CLL in CanadaOctober 6, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
‘Practice-changing’ treatments emerging in AMLOctober 6, 2016Leukemia, Myelodysplasia, TransplantationAML
Doc offers advice on choosing a frontline TKIOctober 6, 2016Leukemia, Myelodysplasia, TransplantationCML
Inflammation may predict transformation to AMLOctober 5, 2016AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Medicare doesn’t lower TKI costs enough, study suggestsOctober 4, 2016Leukemia, Myelodysplasia, TransplantationPharmacyCML
Ponatinib approved to treat CML, ALL in JapanSeptember 30, 2016Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
Study shows RT underused in developing countriesSeptember 29, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Cells might protect cancer patients from infectionSeptember 27, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues